Matches in Wikidata for { <http://www.wikidata.org/entity/Q57121118> ?p ?o ?g. }
Showing items 1 to 31 of
31
with 100 items per page.
- Q57121118 description "im April 2016 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57121118 description "wetenschappelijk artikel" @default.
- Q57121118 description "наукова стаття, опублікована у квітні 2016" @default.
- Q57121118 name "Interim Results From ERADICATE: An Open-Label Phase 2 Study of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Castration-Resistant Prostate Cancer Subjects With Symptomatic Bone Metastases" @default.
- Q57121118 name "Interim Results From ERADICATE: An Open-Label Phase 2 Study of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Castration-Resistant Prostate Cancer Subjects With Symptomatic Bone Metastases" @default.
- Q57121118 type Item @default.
- Q57121118 label "Interim Results From ERADICATE: An Open-Label Phase 2 Study of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Castration-Resistant Prostate Cancer Subjects With Symptomatic Bone Metastases" @default.
- Q57121118 label "Interim Results From ERADICATE: An Open-Label Phase 2 Study of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Castration-Resistant Prostate Cancer Subjects With Symptomatic Bone Metastases" @default.
- Q57121118 prefLabel "Interim Results From ERADICATE: An Open-Label Phase 2 Study of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Castration-Resistant Prostate Cancer Subjects With Symptomatic Bone Metastases" @default.
- Q57121118 prefLabel "Interim Results From ERADICATE: An Open-Label Phase 2 Study of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Castration-Resistant Prostate Cancer Subjects With Symptomatic Bone Metastases" @default.
- Q57121118 P1433 Q57121118-4C2E03A3-091E-4977-919E-6E8D3BAC1E8C @default.
- Q57121118 P1476 Q57121118-0520C322-382D-49C7-AB12-03B9C5986147 @default.
- Q57121118 P304 Q57121118-C47ECBEC-EB79-466A-A48F-C0095C8BB369 @default.
- Q57121118 P31 Q57121118-C08F3069-6D6E-427A-A6E5-57EA351CCA6E @default.
- Q57121118 P31 Q57121118-cd0e9723-ea39-4ab8-99a7-cd0c1b74664d @default.
- Q57121118 P407 Q57121118-76B315CC-8AB0-4CA4-B4A1-5F84BEB2BE84 @default.
- Q57121118 P433 Q57121118-62C9B0B6-BA2D-45A8-89A5-A9C20E1E9628 @default.
- Q57121118 P478 Q57121118-7A2C6788-545D-4D4F-A9BD-3891CCCB2134 @default.
- Q57121118 P577 Q57121118-174EE4D0-8077-4136-BFD7-0E1D18184D53 @default.
- Q57121118 P698 Q57121118-B848B5E5-A64D-4298-9713-D58521173C2E @default.
- Q57121118 P698 27167841 @default.
- Q57121118 P1433 Q26867024 @default.
- Q57121118 P1476 "Interim Results From ERADICATE: An Open-Label Phase 2 Study of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Castration-Resistant Prostate Cancer Subjects With Symptomatic Bone Metastases" @default.
- Q57121118 P304 "3-7" @default.
- Q57121118 P31 Q13442814 @default.
- Q57121118 P31 Q7318358 @default.
- Q57121118 P407 Q1860 @default.
- Q57121118 P433 "4 Suppl 5" @default.
- Q57121118 P478 "14" @default.
- Q57121118 P577 "2016-04-01T00:00:00Z" @default.
- Q57121118 P698 "27167841" @default.